Selection of relevant evidence Clause Samples

Selection of relevant evidence. ‌ The literature search outlined above identified 1937 records (1184 unique citations), a further three citations were identified by hand searching reference lists of other studies, and five records were identified in targeted website searches and the grey literature. The following exclusion criteria were applied: • Wrong publication or study type– excludes narrative reviews, conference abstracts and editorials, and non-comparative studies (i.e. single arm, observational studies) • Wrong population – excludes pharmacists practicing in pharmacies other than community pharmacies (i.e. in clinic or hospital pharmacies) • Wrong intervention – excludes studies of interventions that do not align with CIs as described in Section 3.1.1 (e.g. structured medication reviews, services exceeding 15 minutes duration, specific interventions or programs requiring protocol training) • Wrong comparator – excludes studies that do not include a comparator group of delivery of services without the CI • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1 • Not in English – excludes studies not published in English language or those that do not include at least some information (e.g. a summary) in English The exclusion of citations from the searches is presented in Table 3.3.
View Source
Selection of relevant evidence. ‌ The literature search outlined above identified 1976 unique citations. The following exclusion criteria were applied: • Wrong publication type– excludes narrative reviews. • Wrong intervention – excludes studies that examined the use of DAAs or similar compliance aids as part of a more comprehensive pharmacy care program or were part of a multifaceted pharmacy intervention that included pharmacist’s medication follow-up, education, counselling, home visits, or refill reminders. Studies that evaluated the use of DAAs that are packed by the patient (or self-packed) were excluded. Studies that assessed the use of automated medication dispensing devices were excluded.5 • Wrong comparator – excludes studies that compared DAAs with other compliance aids. • Wrong population – excludes RACF patients, hospital inpatients, recently discharged patients, or patients with infectious disease requiring short treatment duration. • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1. • Not in English – excludes studies not published in English language or those that do not include at least some information (e.g. a summary) in English. • Superseded – excludes systematic reviews that have been updated. The exclusion of citations from the searches is presented in Table 3.3.
View Source
Selection of relevant evidence. ‌ The literature search outlined above identified 48 unique citations. The following a priori exclusion criteria were applied: • Wrong population – excludes residential aged care facility (RACF) patients and hospital inpatients. • Wrong intervention – excludes studies that did not examine a SS service or similar intervention, and studies that examined the supply of medicines related to opioid substitution therapy. • Wrong comparator – excludes studies that compared SS with other pharmacy-led programs. • Wrong outcomes – excludes studies that do not assess one of the outcomes outlined in Section 3.1.1.
View Source

Related to Selection of relevant evidence

  • Notification of Recall Notification of recall from layoff shall be sent by certified mail, return receipt requested, deliverable to addressee only, to the employee's last known address. The notice shall give the employee a minimum of ten (10) calendar days within which to respond after the notice of recall has been mailed. Employees who decline recall or who, in the absence of extenuating circumstances, fail to respond within the time set for return to work, shall be presumed to have resigned and their name shall be removed from the seniority and preferred eligibility list.

  • Certification of Residency, etc Customer certifies that it is a resident of the United States and shall notify Bank of any changes in residency. Bank may rely upon this certification or the certification of such other facts as may be required to administer Bank's obligations hereunder. Customer shall indemnify Bank against all losses, liability, claims or demands arising directly or indirectly from any such certifications.

  • Notification of Results Within 10 days after satisfactory inspection and/or testing of Interconnection Facilities built by the Interconnection Customer (including, if applicable, inspection and/or testing after correction of defects or failures), the Interconnected Transmission Owner shall confirm in writing to the Interconnection Customer and Transmission Provider that the successfully inspected and tested facilities are acceptable for energization.

  • Termination of Requirement Cash Collateral (or the appropriate portion thereof) provided to reduce Issuing Bank’s Fronting Exposure shall no longer be required to be held as Cash Collateral pursuant to this Section 2.19 following (i) the elimination of the applicable Fronting Exposure (including by the termination of Defaulting Lender status of the applicable Lender) or (ii) the determination by Administrative Agent and the Issuing Banks that there exists excess Cash Collateral; provided that, subject to the other provisions of this Section 2.19, the Person providing Cash Collateral and each Issuing Bank may agree that Cash Collateral shall be held to support future anticipated Fronting Exposure; provided, further, that to the extent that such Cash Collateral was provided by Borrower, such Cash Collateral shall remain subject to the security interest granted pursuant to the Loan Documents.

  • Determination of Responsiveness 28.1 The Procuring Entity's determination of a Tender's responsiveness is to be based on the contents of the Tender itself, as defined in ITT28.2.